Latest filing published 02 Apr 2018 for Cardiome Pharma Corp., €13k.
David D. McMasters discloses dealings in Cardiome Pharma Corp. to SEDI. The record holds 9 filings, for trades running from 1 November 2012 to 28 March 2018.
Every open-market trade on record is a purchase: 1 purchase worth €69k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 7 option exercises.
The latest filing, published on 2 April 2018, reports an option exercise of €13k in Cardiome Pharma Corp. The most recent open-market purchase was published on 15 August 2016, 3,723 days ago. The median gap between a trade and its publication by SEDI is 5 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations